21.09.2015 13:20:54
|
Sangamo Reports Updated Clinical Data From ZFP Therapeutic Program For HIV
(RTTNews) - Sangamo BioSciences, Inc. (SGMO) presented data demonstrating sustained functional control of viral load in the absence of antiretroviral drugs in two of three HIV-infected subjects treated in Cohort 3 of its Phase 1/2, or SB-728-1101, study of its ZFP Therapeutic, or SB-728-T, for the treatment of HIV/AIDS.
The company's scientists reported on the progress of two of three subjects in Cohort 3, who had received an SB-728 product that included CCR5 modified CD8 T-cells. These patients' regimen differed from subjects treated in other cohorts in the 1101 study, who had received only CCR5-modified CD4 T-cells after Cytoxan preconditioning. The Cohort 3 treatment regimen was designed to test whether inclusion of CCR5-modified CD8 T-cells, the immune cells responsible for controlling viral infections, could improve HIV viral load control.
"The ability of subjects treated in Cohort 3 to suppress and sustain control of viral load, combined with durable increases in CD4 and CD8 cells, provide support for our hypothesis of an immunologic mechanism of action for SB-728," said Dale Ando, Sangamo's vice president of therapeutic development and chief medical officer.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sangamo Therapeutics Incmehr Nachrichten
16:03 |
Schwache Performance in New York: NASDAQ Composite fällt zum Handelsstart (finanzen.at) | |
17.12.24 |
NASDAQ-Handel NASDAQ Composite verliert schlussendlich (finanzen.at) | |
17.12.24 |
NASDAQ Composite Index-Papier Sangamo Therapeutics-Aktie: So viel Gewinn hätte ein Investment in Sangamo Therapeutics von vor einem Jahr abgeworfen (finanzen.at) | |
16.12.24 |
Optimismus in New York: Letztendlich Pluszeichen im NASDAQ Composite (finanzen.at) | |
16.12.24 |
NASDAQ Composite aktuell: So entwickelt sich der NASDAQ Composite am Montagnachmittag (finanzen.at) | |
16.12.24 |
Pluszeichen in New York: Anleger lassen NASDAQ Composite am Mittag steigen (finanzen.at) | |
16.12.24 |
Handel in New York: Zum Start Gewinne im NASDAQ Composite (finanzen.at) | |
13.12.24 |
Optimismus in New York: NASDAQ Composite letztendlich mit Zuschlägen (finanzen.at) |